EUVIMEDEUVIMED entdecken
Open Access

Doxycycline Enhances Anticancer Activity of Zoledronic Acid via Inducing ROS and Autophagy in Osteosarcoma Cell Lines

Yi-An Li, Hsuan-Ying Chen, Chien-Sheng Hsu, Shun-Cheng Tseng, Eric Hwang, Cheng-Pu Hsieh, Shih-Chieh Hung, Yi-Fu Huang

International Journal of Medical Sciences · 2025

DOI: 10.7150/ijms.108086 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Medical Sciences, 2025. Verfasst von Yi-An Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Translational Medicine and New Drug Development, School of Medicine, China Medical University, Taichung, Taiwan. Hauptthemen laut MEDLINE: Zoledronic Acid, Osteosarcoma, Doxycycline, Bone Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Zoledronic AcidOsteosarcomaDoxycyclineBone NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsHumansAutophagyReactive Oxygen SpeciesCell Line, TumorApoptosisDrug SynergismCell SurvivalCell Proliferation

Stichwörter der Autor:innen

ROSautophagydoxycyclineosteosarcomazoledronic acid

Substanzen

Zoledronic AcidDoxycyclineReactive Oxygen Species

Autor:innen und Institutionen

  • Institute of Translational Medicine and New Drug Development, School of Medicine, China Medical University, Taichung, Taiwan.
  • Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.
  • Orthopaedic Department, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Department of Orthopedic Surgery, Changhua Christian Hospital, Changhua, Taiwan.
  • Orthopedics & Sports Medicine Laboratory, Changhua Christian Hospital, Changhua, Taiwan.
  • Frontier Molecular Medical Research Center in Children, Changhua Christian Children Hospital, Changhua, Taiwan.

Zitieren

APA

Li, Y. A., Chen, H. Y., Hsu, C. S., Tseng, S. C., Hwang, E., Hsieh, C. P., Hung, S. C., & Huang, Y. F. (2025). Doxycycline Enhances Anticancer Activity of Zoledronic Acid via Inducing ROS and Autophagy in Osteosarcoma Cell Lines. International Journal of Medical Sciences. https://doi.org/10.7150/ijms.108086

Vancouver

Li YA, Chen HY, Hsu CS, Tseng SC, Hwang E, Hsieh CP, et al. Doxycycline Enhances Anticancer Activity of Zoledronic Acid via Inducing ROS and Autophagy in Osteosarcoma Cell Lines. International Journal of Medical Sciences. 2025. doi:10.7150/ijms.108086

BibTeX
@article{Li2025,
  author = {Li, Yi-An and Chen, Hsuan-Ying and Hsu, Chien-Sheng and Tseng, Shun-Cheng and Hwang, Eric and Hsieh, Cheng-Pu and Hung, Shih-Chieh and Huang, Yi-Fu},
  title = {Doxycycline Enhances Anticancer Activity of Zoledronic Acid via Inducing ROS and Autophagy in Osteosarcoma Cell Lines},
  journal = {International Journal of Medical Sciences},
  year = {2025},
  doi = {10.7150/ijms.108086}
}
Kostenlos starten →